Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients

Jara Valtueña1, Gerardo Martínez-García2, Daniel Ruiz-Sánchez1

  • 1Department of Dermatology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Insights

COVID-19 causes skin lesions with vascular damage, including cell growth and lumen obliteration. This obliterative microangiopathy, involving complement activation, contributes to bleeding risk, suggesting anticoagulation alone may be insufficient.

Area of Science:

  • Pathology
  • Vascular Biology
  • Immunology

Background:

  • Coronavirus disease 2019 (COVID-19) is a multi-organ illness.
  • Patients often exhibit a procoagulant state and hypoxemia.
  • Vascular tissue damage mechanisms in COVID-19 remain unclear, with limited histological data.

Purpose of the Study:

  • To investigate the histology of skin lesions in COVID-19 patients.
  • To elucidate the underlying pathology of vascular damage in COVID-19.
  • To understand the disease mechanisms in living patients.

Main Methods:

  • Histological examination of five skin lesions from adult COVID-19 patients.
  • Deep tissue analysis to identify pathological changes.

Main Results:

  • Observed a vasculopathic reaction with endothelial and myointimal cell growth.
  • Identified vascular lumen obliteration, erythrocyte, and serum extravasation.
  • Detected C4d and C3 deposition in vascular walls, alongside epidermal hyperplasia.

Conclusions:

  • COVID-19 may involve an obliterative microangiopathy with complement activation.
  • Increased vascular permeability and microangiopathy contribute to lumen obliteration and hemorrhage.
  • Findings suggest anticoagulation may be insufficient, highlighting potential therapeutic targets.
Abstract